Identification | Back Directory | [Name]
SULFANILYLUREA | [CAS]
547-44-4 | [Synonyms]
a435 A 435 Urenil Uramid Uractyl Euvernil Sulfaurea Urosulfan NSC 78438 NSC 78438Q Urosulfane Sulphaurea Sulfanyluree A 435 (amide) sulfacarbamide sulfanilyl-ure SULFANILYLUREA Sulphacarbamide 1-Sulfanilylurea 4-Sulfacarbamide Sulfanilcarbamid Sulfanylharnstoff Urea, sulfanilyl- N-Sulfanilcarbamide p-Aminobenzenesulfonylurea (4-aminophenyl)sulfonylurea [(p-Aminophenyl)sulfonyl]urea 1-(4-azanylphenyl)sulfonylurea [(4-aMinobenzene)sulfonyl]urea 1-(4-Aminobenzenesulfonyl)urea Sulfanilamide, N(sup1)-carbamoyl- Sulphaminoic acid N-carbamoylamide N-[(4-Aminophenyl)sulphonyl]urea (S 4-AMino-N-carbaMoylbenzenesulfonaMide 4-amino-n-(aminocarbonyl)-benzenesulfonamid 4-Amino-N-(aminocarbonyl)benzenesulfonamide Benzenesulfonamide,4-amino-N-(aminocarbonyl)- Benzenesulfonamide, 4-amino-N-(aminocarbonyl)- 1-Amino-4-([(aminocarbonyl)amino]sulfonyl)benzene | [EINECS(EC#)]
208-922-7 | [Molecular Formula]
C7H9N3O3S | [MDL Number]
MFCD00025437 | [MOL File]
547-44-4.mol | [Molecular Weight]
215.23 |
Chemical Properties | Back Directory | [Melting point ]
146-148° (slight dec) | [density ]
1.4565 (rough estimate) | [refractive index ]
1.6630 (estimate) | [storage temp. ]
Keep in dark place,Inert atmosphere,2-8°C | [solubility ]
DMSO : ≥ 28 mg/mL (130.09 mM) | [pka]
pKa 1.78(H2O
t = 25
I = 0.05) (Uncertain);5.42(H2O
t = 25
I = 0.05) (Uncertain) | [Water Solubility ]
2.333g/L(20 ºC) | [InChI]
InChI=1S/C7H9N3O3S/c8-5-1-3-6(4-2-5)14(12,13)10-7(9)11/h1-4H,8H2,(H3,9,10,11) | [InChIKey]
WVAKABMNNSMCDK-UHFFFAOYSA-N | [SMILES]
C1(S(NC(N)=O)(=O)=O)=CC=C(N)C=C1 |
Hazard Information | Back Directory | [Chemical Properties]
White solid | [Uses]
antibacterial | [Definition]
ChEBI: Sulfacarbamide is a sulfonamide and a member of benzenes. | [World Health Organization (WHO)]
Sulfacarbamide, a sulfonamide anti-infective agent, was
introduced in the 1940's for the treatment of bacterial infections. The importance of
sulfonamides has subsequently decreased as a result of increasing bacterial
resistance and their replacement by antibiotics which are generally more active
and less toxic. The Sulfacarbamide are known to cause serious adverse effects
such as renal toxicity, sometimes fatal exfoliative dermatitis and erythema
multiforma and dangerous adverse reactions affecting blood formation such as
agranulocytosis and haemolytic or aplastic anaemia. Sulfacarbamide still remains
available in at least one country for the treatment of urinary infections. | [storage]
Store at -20°C |
|
|